0 NASDAQ Companies - February 26, 2019Vericel Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Full-Year 2019 Financial GuidanceRead More
0 NASDAQ Companies - February 26, 2019TG Therapeutics Announces Initiation of Phase I First-in-Human Clinical Trial of its Anti-CD47/CD19 Bispecific Antibody, TG-1801, in Patients with Relapsed or Refractory B-cell LymphomaRead More
0 NASDAQ Companies - February 26, 2019Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2018 Financial ResultsRead More
0 NASDAQ Companies - February 26, 2019Atara Biotherapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Recent Operational ProgressRead More
0 NASDAQ Companies - February 26, 2019Aehr to Present and Exhibit at the TestConX Workshop in Mesa, AZ March 3-6, 2019Read More
0 NASDAQ Companies - February 26, 2019Kura Oncology to Report Fourth Quarter and Full Year 2018 Financial ResultsRead More
0 NASDAQ Companies - February 26, 2019Kiniksa Pharmaceuticals to Present at the Barclays Global Healthcare ConferenceRead More
0 NASDAQ Companies - February 26, 2019New Data Shows Addition of BeyondSpring’s Plinabulin Reverses Neulasta’s Potential Immune-Suppressive Phenotype in Treating Chemotherapy-Induced NeutropeniaRead More
0 NASDAQ Companies - February 26, 2019Latest PacBio Sequencing Advancements Including Preview of Sequel II System to be Featured at Annual AGBT ConferenceRead More
0 NASDAQ Companies - February 26, 2019CytomX Therapeutics 2019 Research and Development Day Highlights Clinical Data from Lead Programs and the Broad Potential of Probody™ Therapeutic PlatformRead More
